Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Vivek Subbiah

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-6064-6837; OpenAlex author ID A5043675371. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 1, last author 1)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2004: 1 trial · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper, 1 trial · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 6

  1. Redefining pancreatic cancer management with tumor-agnostic precision medicine. First author DOI 10.1093/carcin/bgae066↗
  2. Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Tri… Co-author DOI 10.1007/s12029-023-00930-7↗
  3. Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer. Last author DOI 10.1200/po.23.00252↗
  4. Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies. Co-author DOI 10.1200/po.20.00494↗
  5. Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma. Co-author DOI 10.1159/000496018↗
  6. Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience. Co-author DOI 10.18632/oncotarget.19897↗

Trials 2

  1. The Registry of Oncology Outcomes Associated With Testing and Treatment Principal investigator NCT04028479↗
  2. Trial of Curcumin in Advanced Pancreatic Cancer Principal investigator NCT00094445↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Neha K. Reddy · 1 shared paper, 2024 · strength 0.46
  2. Jennifer Johnson · 1 shared trial, 2021 · strength 0.29
  3. Razelle Kurzrock · 1 shared trial, 2021 · strength 0.29
  4. Raymond Bergan · 1 shared trial, 2021 · strength 0.29
  5. Funda Meric-Bernstam · 2 shared papers, 2017–2023 · strength 0.22
  6. Robert A. Wolff · 2 shared papers, 2017–2023 · strength 0.22
  7. David S. Hong · 2 shared papers, 2017–2023 · strength 0.22
  8. Aung Naing · 2 shared papers, 2017–2023 · strength 0.22
  9. Deepak Bhamidipati · 1 shared paper, 2023 · strength 0.22
  10. Jane Elizabeth Rogers · 1 shared paper, 2023 · strength 0.17
  11. Rishi Surana · 1 shared paper, 2023 · strength 0.17
  12. Jordi Ahnert Rodon · 1 shared paper, 2023 · strength 0.17
  13. Brandon George Smaglo · 1 shared paper, 2023 · strength 0.17
  14. Timothy Anthony Yap · 1 shared paper, 2023 · strength 0.17
  15. Shubham Pant · 1 shared paper, 2023 · strength 0.17
  16. Albert Grinshpun · 1 shared paper, 2019 · strength 0.12
  17. Jason Roszik · 1 shared paper, 2019 · strength 0.12
  18. Ayala Hubert · 1 shared paper, 2019 · strength 0.12
  19. Timothy Lewis Cannon · 1 shared paper, 2021 · strength 0.11
  20. Emanuel F. Petricoin · 1 shared paper, 2021 · strength 0.11
  21. Andrew Eugene Hendifar · 1 shared paper, 2021 · strength 0.11
  22. Isha Singh · 1 shared paper, 2021 · strength 0.11
  23. Eric Andrew Collisson · 1 shared paper, 2021 · strength 0.11
  24. Samuel Jacob Klempner · 1 shared paper, 2021 · strength 0.11
  25. Eileen Mary O'Reilly · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.